Product Distribution

September 5, 2024

The Reality About Weight-loss Tablets

Are Weight-loss Medications Worth Trying? These medications are not recommended for individuals with several endocrine neoplasia (MEN) disorder kind 2, background of thyroid cancer cells or pancreatitis, pregnancy, and current use of certain prescription drugs. Though uncommon, extreme side...

Read more →
September 5, 2024

Anti-obesity Drug Exploration: Advances And Difficulties Nature Examines Medication Exploration

Randomized Regulated Trial Of Tesomet For Weight-loss In Hypothalamic Excessive Weight European Journal Of Endocrinology For instance, it is known that timeless serotoninergic neurons have in their membranes receptors for NE, and vice versa (Gorea & Adrien, 1988). Taken entirely, the crossway at...

Read more →
September 5, 2024

Experts Talk About Research Right Into A Possible Brand-new Weight Problems Medication, As Released In The Lancet

Medicines Heading To Take On Excessive Weight Epidemic The quest of AOMs has actually been an enduring effort thrust recently by a number of concurrent advancements. It seems probable that a 20% or greater reduction in body weight might yet be possible based on late-phase professional reports. If...

Read more →
September 5, 2024

Can Fat Burning Medications Really Assist You Reduce Weight?

The Fact Concerning Weight-loss Tablets A medical gadget instead of a medicine, Plenity was FDA-cleared in 2019 for people with a BMI of 24 to 40. The therapy has actually experienced raised limelights considering that the surge of GLP-1 receptor agonists. Setmelanotide is a melanocortin-4 receptor...

Read more →
September 5, 2024

Anti-obesity Drugs: An Evaluation Concerning Their Impacts And Safety And Security

Pharmacotherapy Of Excessive Weight: An Upgrade On The Offered Medications And Drugs Under Examination A number of clinical tests have actually been carried out to examine the effectiveness of tesofensine in fat burning. Outcomes have shown significant decreases in body weight, body mass index...

Read more →
Welcome to MediQuest Pharmaceuticals, where innovation meets excellence in the pharmaceutical industry. I am Michael Johnson, the founder and driving force behind MediQuest Pharmaceuticals. With over two decades of experience in drug development and pharmaceutical regulations, I have dedicated my career to advancing healthcare through innovative pharmaceutical solutions. Born and raised in the bustling city of Boston, my fascination with science began at a young age, nurtured by countless hours spent in the local library reading about chemistry and biology. This passion led me to pursue a degree in Medicinal Chemistry at the University of Massachusetts, followed by a Ph.D. in Pharmaceutical Sciences. After completing my education, I ventured into the pharmaceutical industry, where I gained extensive experience in various facets of drug development and manufacturing.